Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Vehicle Controlled, Double Blinded, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure

NCT02998840 is registered in ClinicalTrials.gov with AOBiome LLC as lead sponsor.

NCT NCT02998840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02998840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Vehicle Controlled, Double Blinded, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
Lead sponsor
AOBiome LLC
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2016
Completion date
June 26, 2017
Enrollment
132 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, stage i, prehypertension